Breaking News Instant updates and real-time market news.

CALX

Calix

$57.95 /

-0.38 (-0.65%)

16:15
01/25/23
01/25
16:15
01/25/23
16:15

Calix says margins continued to move higher after bottoming in Q2

The company said, "In the fourth quarter of 2022, our gross margin continued to move higher after bottoming in the second quarter of 2022 as our supply chain began to normalize and our platform solutions continued to grow. GAAP gross margin decreased 60 basis points year-over-year to 51.1% primarily as we received a U.S. tariff refund in the year ago period, while non-GAAP gross margin increased 30 basis points to 51.6% reflecting an improving supply chain and was slightly above our guidance range."

  • 26

    Jan

  • 12

    Mar

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Friedrich Vorwerk downgraded to Hold from Buy at Berenberg » 04:43
02/03/23
02/03
04:43
02/03/23
04:43
FRVWY

Friedrich Vorwerk

$3.50 /

-0.25 (-6.67%)

Berenberg analyst Lasse…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRVWY Friedrich Vorwerk
$3.50 /

-0.25 (-6.67%)

01/31/23 Jefferies
Vorwerk Group SE downgraded to Hold from Buy at Jefferies
Downgrade
Asos downgraded to Hold from Buy at Deutsche Bank » 04:40
02/03/23
02/03
04:40
02/03/23
04:40
ASOMY

Asos

$12.01 /

+0.83 (+7.42%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASOMY Asos
$12.01 /

+0.83 (+7.42%)

02/01/23 HSBC
Asos upgraded to Hold from Reduce at HSBC
01/24/23 Morgan Stanley
Asos price target raised to 730 GBp from 660 GBp at Morgan Stanley
01/13/23 JPMorgan
Asos price target lowered to 1,000 GBp from 1,170 GBp at JPMorgan
01/13/23 Societe Generale
Asos price target raised to 1,180 GBp from 1,072 GBp at Societe Generale
Downgrade
Pets at Home Group downgraded to Hold from Buy at Deutsche Bank » 04:39
02/03/23
02/03
04:39
02/03/23
04:39
PAHGF

Pets at Home Group

$3.42 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAHGF Pets at Home Group
$3.42 /

+ (+0.00%)

02/02/23 Liberum
Pets at Home Group downgraded to Hold from Buy at Liberum
11/03/22 Berenberg
Pets at Home Group price target lowered to 370 GBp from 470 GBp at Berenberg
08/09/22 Jefferies
Pets at Home Group initiated with a Buy at Jefferies
07/04/22 RBC Capital
Pets at Home Group downgraded to Underperform from Sector Perform at RBC Capital
Downgrade
Kingfisher downgraded to Hold from Buy at Deutsche Bank » 04:39
02/03/23
02/03
04:39
02/03/23
04:39
KGFHY

Kingfisher

$7.17 /

+0.26 (+3.76%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KGFHY Kingfisher
$7.17 /

+0.26 (+3.76%)

12/02/22 Deutsche Bank
Kingfisher price target lowered to 275 GBp from 280 GBp at Deutsche Bank
11/17/22 JPMorgan
Kingfisher price target lowered to 210 GBp from 220 GBp at JPMorgan
11/07/22 Credit Suisse
Kingfisher downgraded to Neutral from Outperform at Credit Suisse
09/27/22 Deutsche Bank
Kingfisher price target raised to 280 GBp from 270 GBp at Deutsche Bank
Upgrade
Inditex upgraded to Hold from Sell at Deutsche Bank » 04:38
02/03/23
02/03
04:38
02/03/23
04:38
IDEXY

Inditex

$15.76 /

-0.19 (-1.19%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IDEXY Inditex
$15.76 /

-0.19 (-1.19%)

12/16/22 Societe Generale
Inditex downgraded to Hold from Buy at Societe Generale
12/15/22 Deutsche Bank
Inditex price target raised to EUR 23 from EUR 22.50 at Deutsche Bank
12/02/22 Morgan Stanley
Inditex assumed with an Equal Weight at Morgan Stanley
09/15/22 Credit Suisse
Inditex price target raised to EUR 21.50 from EUR 20.50 at Credit Suisse
Upgrade
B&M European Value Retail upgraded to Buy from Hold at Deutsche Bank » 04:37
02/03/23
02/03
04:37
02/03/23
04:37
BMRRY

B&M European Value Retail

$23.34 /

+0.85 (+3.78%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMRRY B&M European Value Retail
$23.34 /

+0.85 (+3.78%)

01/06/23 JPMorgan
B&M European Value price target lowered to EUR 540 from EUR 555 at JPMorgan
01/06/23 Barclays
B&M European Value price target raised to 485 GBp from 475 GBp at Barclays
01/06/23 Deutsche Bank
B&M European Value price target raised to 460 GBp from 415 GBp at Deutsche Bank
12/30/22 Credit Suisse
Credit Suisse sees some U.K. retailers increasing guidance
Upgrade
Marks & Spencer upgraded to Buy from Hold at Deutsche Bank » 04:37
02/03/23
02/03
04:37
02/03/23
04:37
MAKSY

Marks & Spencer

$4.00 /

+0.19 (+4.99%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAKSY Marks & Spencer
$4.00 /

+0.19 (+4.99%)

MAKSY Marks & Spencer
$4.00 /

+0.19 (+4.99%)

01/13/23 Barclays
Marks & Spencer price target raised to 165 GBp from 155 GBp at Barclays
01/13/23 JPMorgan
Marks & Spencer price target raised to 115 GBp from 100 GBp at JPMorgan
01/13/23 Citi
Marks & Spencer price target raised to 150 GBp from 125 GBp at Citi
12/30/22 Credit Suisse
Credit Suisse sees some U.K. retailers increasing guidance
Upgrade
Standard Chartered upgraded to Buy from Hold at Investec » 04:34
02/03/23
02/03
04:34
02/03/23
04:34
SCBFF

Standard Chartered

$8.15 /

+ (+0.00%)

Investec analyst Ian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCBFF Standard Chartered
$8.15 /

+ (+0.00%)

02/01/23 Goldman Sachs
Standard Chartered downgraded to Neutral from Buy at Goldman Sachs
01/16/23 Deutsche Bank
Standard Chartered downgraded to Hold from Buy at Deutsche Bank
01/06/23 Investec
Standard Chartered downgraded to Hold from Buy at Investec
12/06/22 JPMorgan
Standard Chartered price target raised to 800 GBp from 770 GBp at JPMorgan
Recommendations
Amazon.com price target raised to $123 from $119 at Piper Sandler » 04:32
02/03/23
02/03
04:32
02/03/23
04:32
AMZN

Amazon.com

$112.65 /

+7.48 (+7.11%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

02/02/23 Morgan Stanley
Meta Platforms price target raised to $190 from $130 at Morgan Stanley
02/01/23 Oppenheimer
Oppenheimer says channel checks support below-consensus AWS estimates
02/01/23 Morgan Stanley
Buy with Prime could be $3.5B-plus EBIT business for Amazon, says Morgan Stanley
01/30/23 UBS
Amazon's Buy with Prime puts up to 14% of Shopify revenue at risk, says UBS
AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

AMZN Amazon.com
$112.65 /

+7.48 (+7.11%)

Recommendations
Alphabet price target lowered to $120 from $122 at Piper Sandler » 04:30
02/03/23
02/03
04:30
02/03/23
04:30
GOOGL

Alphabet

$107.71 /

+7.275 (+7.24%)

, GOOG

Alphabet

$108.77 /

+7.375 (+7.27%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

02/02/23 Morgan Stanley
Meta Platforms price target raised to $190 from $130 at Morgan Stanley
01/31/23 BofA
Alphabet price target raised to $119 at BofA ahead of earnings
01/30/23 KeyBanc
Trade Desk price target lowered to $55 from $56 at KeyBanc
01/30/23 KeyBanc
Alphabet price target lowered to $117 from $118 at KeyBanc
GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

02/02/23 Morgan Stanley
Meta Platforms price target raised to $190 from $130 at Morgan Stanley
01/31/23 BofA
Alphabet price target raised to $119 at BofA ahead of earnings
01/30/23 KeyBanc
Trade Desk price target lowered to $55 from $56 at KeyBanc
01/30/23 KeyBanc
Alphabet price target lowered to $117 from $118 at KeyBanc
GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

GOOGL Alphabet
$107.71 /

+7.275 (+7.24%)

GOOG Alphabet
$108.77 /

+7.375 (+7.27%)

Recommendations
Gilead price target raised to $112 from $111 at Piper Sandler » 04:28
02/03/23
02/03
04:28
02/03/23
04:28
GILD

Gilead

$81.37 /

-2.625 (-3.13%)

Piper Sandler analyst Do…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$81.37 /

-2.625 (-3.13%)

GILD Gilead
$81.37 /

-2.625 (-3.13%)

01/30/23 Truist
Truist sees potential pressure on Seagen's Padcev in Q4
01/19/23 Piper Sandler
Gilead price target raised to $111 from $104 at Piper Sandler
01/03/23 RBC Capital
RBC downgrades Gilead, says drivers need time to play out
01/03/23 RBC Capital
Gilead downgraded to Sector Perform from Outperform at RBC Capital
GILD Gilead
$81.37 /

-2.625 (-3.13%)

GILD Gilead
$81.37 /

-2.625 (-3.13%)

GILD Gilead
$81.37 /

-2.625 (-3.13%)

Recommendations
Conmed price target raised to $118 from $108 at Piper Sandler » 04:27
02/03/23
02/03
04:27
02/03/23
04:27
CNMD

Conmed

$107.27 /

+8.02 (+8.08%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNMD Conmed
$107.27 /

+8.02 (+8.08%)

CNMD Conmed
$107.27 /

+8.02 (+8.08%)

02/02/23 Piper Sandler
Conmed price target raised to $118 from $108 at Piper Sandler
10/26/22 Piper Sandler
Conmed price target lowered to $108 from $118 at Piper Sandler
10/26/22 Piper Sandler
Piper Sandler keeps Neutral on Integra after results, favors Conmed and Tandem
10/14/22 Needham
Conmed price target lowered to $90 from $123 at Needham
CNMD Conmed
$107.27 /

+8.02 (+8.08%)

CNMD Conmed
$107.27 /

+8.02 (+8.08%)

Initiation
Privia Health initiated with a Buy at Goldman Sachs » 04:26
02/03/23
02/03
04:26
02/03/23
04:26
PRVA

Privia Health

$27.62 /

+0.05 (+0.18%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRVA Privia Health
$27.62 /

+0.05 (+0.18%)

PRVA Privia Health
$27.62 /

+0.05 (+0.18%)

01/17/23 Piper Sandler
Piper Sandler would be a buyer of Privia Health following CMS data
01/09/23 BTIG
Privia Health price target lowered to $40 from $45 at BTIG
12/08/22 Stifel
Privia Health initiated with a Buy at Stifel
12/08/22 UBS
Privia Health initiated with a Buy at UBS
PRVA Privia Health
$27.62 /

+0.05 (+0.18%)

  • 17
    Nov
PRVA Privia Health
$27.62 /

+0.05 (+0.18%)

Initiation
Agios Pharmaceuticals initiated with an Overweight at Piper Sandler » 04:25
02/03/23
02/03
04:25
02/03/23
04:25
AGIO

Agios Pharmaceuticals

$30.16 /

+0.74 (+2.52%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGIO Agios Pharmaceuticals
$30.16 /

+0.74 (+2.52%)

AGIO Agios Pharmaceuticals
$30.16 /

+0.74 (+2.52%)

11/17/22 Goldman Sachs
Agios Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs
07/27/22 SVB Securities
Agios Pharmaceuticals upgraded to Outperform from Market Perform at SVB Securities
02/25/22 RBC Capital
Agios Pharmaceuticals price target raised to $67 from $61 at RBC Capital
02/24/22 H.C. Wainwright
Agios Pharmaceuticals price target lowered to $96 from $98 at H.C. Wainwright
AGIO Agios Pharmaceuticals
$30.16 /

+0.74 (+2.52%)

AGIO Agios Pharmaceuticals
$30.16 /

+0.74 (+2.52%)

General news
Market Update: » 03:05
02/03/23
02/03
03:05
02/03/23
03:05
$ECON

Economic Data

/

+

Market Update: Asian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
China economy bounces back thanks to services. » 02:25
02/03/23
02/03
02:25
02/03/23
02:25
$ECON

Economic Data

/

+

China economy bounces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
Piper Sandler economist to hold an analyst/industry conference call » 22:33
02/02/23
02/02
22:33
02/02/23
22:33

Chief Economist Lazar and…

Chief Economist Lazar and Head of Global Policy Perli discuss payrolls and their implications on an Analyst/Industry conference call to be held on February 3 at 8:45 am. Webcast Link

Conference/Events
Cowen medical devices analyst to hold analyst/industry conference call » 22:24
02/02/23
02/02
22:24
02/02/23
22:24

Medical Devices Analyst…

Medical Devices Analyst Jennings, along with Dr. Shephal Doshi, Director of Cardiac Electrophysiology at Pacific Heart Institute, discuss the market dynamics of the U.S. Left Atrial Appendage Closure (LAAC) Duopoly on an Analyst/Industry conference call to be held on February 7 at 12:30 pm. Webcast Link

Syndicate
Avalo Therapeutics 3.77M share Spot Secondary priced at $3.98 » 21:56
02/02/23
02/02
21:56
02/02/23
21:56
AVTX

Avalo Therapeutics

$4.01 /

+0.01 (+0.25%)

SVB Securities and RBC…

SVB Securities and RBC Capital are acting as joint book running managers for the offering.

ShowHide Related Items >><<
AVTX Avalo Therapeutics
$4.01 /

+0.01 (+0.25%)

AVTX Avalo Therapeutics
$4.01 /

+0.01 (+0.25%)

11/09/22 Oppenheimer
Avalo Therapeutics price target lowered to $10 from $17 at Oppenheimer
07/11/22 RBC Capital
Avalo Therapeutics price target lowered to $21 from $24 at RBC Capital
03/03/22 Jefferies
Avalo Therapeutics cut to Hold at Jefferies after pipeline reprioritization
03/03/22 Jefferies
Avalo Therapeutics downgraded to Hold from Buy at Jefferies
AVTX Avalo Therapeutics
$4.01 /

+0.01 (+0.25%)

  • 03
    Feb
Recommendations
Conmed price target raised to $118 from $108 at Piper Sandler » 21:55
02/02/23
02/02
21:55
02/02/23
21:55
CNMD

Conmed

$107.27 /

+8.02 (+8.08%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien raised the firm's price target on Conmed to $118 from $108 and keeps an Overweight rating on the shares. The company unsurprisingly missed on Q4 earnings and revenue due to a previously disclosed Software Implementation issue, but this should be a transitory factor, the analyst tells investors in a research note. Conmed's key growth drivers - the Smoke business, In2Bones and Biorez - remain strong and should stay that way through 2023 and beyond, the firm adds.

ShowHide Related Items >><<
CNMD Conmed
$107.27 /

+8.02 (+8.08%)

CNMD Conmed
$107.27 /

+8.02 (+8.08%)

10/26/22 Piper Sandler
Conmed price target lowered to $108 from $118 at Piper Sandler
10/26/22 Piper Sandler
Piper Sandler keeps Neutral on Integra after results, favors Conmed and Tandem
10/14/22 Needham
Conmed price target lowered to $90 from $123 at Needham
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
CNMD Conmed
$107.27 /

+8.02 (+8.08%)

CNMD Conmed
$107.27 /

+8.02 (+8.08%)

Syndicate
Roivant Sciences 26.67M share Secondary priced at $7.50 » 21:17
02/02/23
02/02
21:17
02/02/23
21:17
ROIV

Roivant Sciences

$7.58 /

-0.99 (-11.55%)

The deal size was…

The deal size was increased to $200M from $150M and priced below last closing price of $7.59. Goldman Sachs, SVB Securities, Cowen and Cantor Fitzgerald are acting as joint book running managers for the offering.

ShowHide Related Items >><<
ROIV Roivant Sciences
$7.58 /

-0.99 (-11.55%)

ROIV Roivant Sciences
$7.58 /

-0.99 (-11.55%)

01/05/23 Citi
Roivant Sciences price target raised to $14 from $11 at Citi
01/04/23 Piper Sandler
Prometheus, Roivant TL1A data look 'highly competitive,' says Piper
12/28/22 Cantor Fitzgerald
Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks
12/27/22 Cantor Fitzgerald
Roivant's upcoming data readouts could move stock higher, says Cantor Fitzgerald
ROIV Roivant Sciences
$7.58 /

-0.99 (-11.55%)

  • 03
    Feb
  • 08
    Nov
ROIV Roivant Sciences
$7.58 /

-0.99 (-11.55%)

Syndicate
Edible Garden 1.62M share Spot Secondary priced at $6.30 » 20:43
02/02/23
02/02
20:43
02/02/23
20:43
EDBL

Edible Garden

$8.35 /

-2.8 (-25.11%)

The deal priced below…

The deal priced below last closing price of $8.35. Maxim and Joseph Gunnar are acting as joint book running managers for the offering.

ShowHide Related Items >><<
EDBL Edible Garden
$8.35 /

-2.8 (-25.11%)

EDBL Edible Garden
$8.35 /

-2.8 (-25.11%)

09/13/22 Maxim
Maxim starts Edible Garden at Buy on consistent produce growth and distribution
09/13/22 Maxim
Edible Garden initiated with a Buy at Maxim
EDBL Edible Garden
$8.35 /

-2.8 (-25.11%)

Hot Stocks
Dutch Bros CEO sells $6.0M in common stock » 20:39
02/02/23
02/02
20:39
02/02/23
20:39
BROS

Dutch Bros

$39.95 /

+1.41 (+3.66%)

In a regulatory filing,…

In a regulatory filing, Dutch Bros disclosed that its CEO Jonathan Ricci sold 160K shares of common stock on February 1 in a total transaction size of $6.0M.

ShowHide Related Items >><<
BROS Dutch Bros
$39.95 /

+1.41 (+3.66%)

BROS Dutch Bros
$39.95 /

+1.41 (+3.66%)

01/26/23 Barclays
Dutch Bros price target raised to $31 from $29 at Barclays
01/24/23 Wedbush
Dutch Bros initiated with a Neutral at Wedbush
01/05/23 Baird
Baird remains very bullish on long-term fundamentals at Dutch Bros
01/05/23 Barclays
Dutch Bros price target lowered to $29 from $30 at Barclays
BROS Dutch Bros
$39.95 /

+1.41 (+3.66%)

  • 16
    Aug
  • 11
    Mar
BROS Dutch Bros
$39.95 /

+1.41 (+3.66%)

BROS Dutch Bros
$39.95 /

+1.41 (+3.66%)

BROS Dutch Bros
$39.95 /

+1.41 (+3.66%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
02/02/23
02/02
20:25
02/02/23
20:25
CI

Cigna

$301.39 /

-11.73 (-3.75%)

, REGN

Regeneron

$751.22 /

-5.9 (-0.78%)

, ZBH

Zimmer Biomet

$127.40 /

-0.3 (-0.23%)

, CHD

Church & Dwight

$79.75 /

-1.665 (-2.05%)

, SAIA

Saia

$287.01 /

-8.69 (-2.94%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Cigna (CI), consensus $4.86... Regneron (REGN), consensus $10.03... Zimmer Biomet (ZBH), consensus $1.83... Church & Dwight (CHD), consensus 60c... Saia (SAIA), consensus $2.83.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$127.40 /

-0.3 (-0.23%)

SAIA Saia
$287.01 /

-8.69 (-2.94%)

REGN Regeneron
$751.22 /

-5.9 (-0.78%)

CI Cigna
$301.39 /

-11.73 (-3.75%)

CHD Church & Dwight
$79.75 /

-1.665 (-2.05%)

CI Cigna
$301.39 /

-11.73 (-3.75%)

01/31/23 JPMorgan
Medicare Advantage final rule more favorable than feared, says JPMorgan
01/03/23 Wells Fargo
Wells Fargo downgrades Cigna to Equal Weight, lowers price target to $355
01/03/23 Wells Fargo
Cigna downgraded to Equal Weight from Overweight at Wells Fargo
11/23/22 Morgan Stanley
Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley
REGN Regeneron
$751.22 /

-5.9 (-0.78%)

01/30/23 Cowen
Regeneron upgraded at Cowen with Eylea 'secure' and pipeline 'delivering'
01/30/23 Cowen
Regeneron upgraded to Outperform from Market Perform at Cowen
01/20/23 JPMorgan
Regeneron upgraded to Overweight from Neutral at JPMorgan
01/09/23 Piper Sandler
Piper 'at a loss' to explain Regeneron Q4 miss for Eylea
ZBH Zimmer Biomet
$127.40 /

-0.3 (-0.23%)

01/09/23 RBC Capital
Zimmer Biomet upgraded to Outperform from Sector Perform at RBC Capital
01/05/23 Piper Sandler
Zimmer Biomet price target raised to $130 from $120 at Piper Sandler
01/05/23 Raymond James
Zimmer Biomet upgraded to Outperform from Market Perform at Raymond James
01/03/23 Evercore ISI
Zimmer Biomet downgraded to In Line at Evercore ISI with FY23 outlook priced in
CHD Church & Dwight
$79.75 /

-1.665 (-2.05%)

01/17/23 Credit Suisse
Church & Dwight upgraded to Outperform from Neutral at Credit Suisse
01/16/23 Morgan Stanley
Church & Dwight upgraded to Overweight from Equal Weight at Morgan Stanley
01/13/23 JPMorgan
Church & Dwight price target raised to $81 from $75 at JPMorgan
12/06/22 Deutsche Bank
Church & Dwight price target raised to $90 from $85 at Deutsche Bank
SAIA Saia
$287.01 /

-8.69 (-2.94%)

01/30/23 Credit Suisse
Saia downgraded to Neutral from Outperform at Credit Suisse
01/09/23 Susquehanna
Saia downgraded to Neutral from Positive at Susquehanna
01/09/23 Morgan Stanley
Saia upgraded to Equal Weight from Underweight at Morgan Stanley
12/01/22 BofA
Saia cut to Underperform at BofA after Q4 shipment update
ZBH Zimmer Biomet
$127.40 /

-0.3 (-0.23%)

SAIA Saia
$287.01 /

-8.69 (-2.94%)

REGN Regeneron
$751.22 /

-5.9 (-0.78%)

CI Cigna
$301.39 /

-11.73 (-3.75%)

CHD Church & Dwight
$79.75 /

-1.665 (-2.05%)

SAIA Saia
$287.01 /

-8.69 (-2.94%)

REGN Regeneron
$751.22 /

-5.9 (-0.78%)

CI Cigna
$301.39 /

-11.73 (-3.75%)

ZBH Zimmer Biomet
$127.40 /

-0.3 (-0.23%)

SAIA Saia
$287.01 /

-8.69 (-2.94%)

REGN Regeneron
$751.22 /

-5.9 (-0.78%)

CI Cigna
$301.39 /

-11.73 (-3.75%)

CHD Church & Dwight
$79.75 /

-1.665 (-2.05%)

REGN Regeneron
$751.22 /

-5.9 (-0.78%)

CI Cigna
$301.39 /

-11.73 (-3.75%)

CHD Church & Dwight
$79.75 /

-1.665 (-2.05%)

Hot Stocks
Nordstrom ends afterhours session up 31% after WSJ report on Ryan Cohen stake  20:16
02/02/23
02/02
20:16
02/02/23
20:16
JWN

Nordstrom

$21.14 /

+1.155 (+5.78%)

 
ShowHide Related Items >><<
JWN Nordstrom
$21.14 /

+1.155 (+5.78%)

JWN Nordstrom
$21.14 /

+1.155 (+5.78%)

01/30/23 Goldman Sachs
Nordstrom initiated with a Neutral at Goldman Sachs
01/20/23 Deutsche Bank
Nordstrom price target lowered to $17 from $21 at Deutsche Bank
01/20/23 BMO Capital
Nordstrom price target lowered to $20 from $23 at BMO Capital
01/20/23 Citi
Nordstrom price target lowered to $17 from $21 at Citi
JWN Nordstrom
$21.14 /

+1.155 (+5.78%)

JWN Nordstrom
$21.14 /

+1.155 (+5.78%)

JWN Nordstrom
$21.14 /

+1.155 (+5.78%)

JWN Nordstrom
$21.14 /

+1.155 (+5.78%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.